Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

416 results
Display

Observation on the correlation between the PIVKAL test for PIVKA-II assay and prothrombin time in patients with coumarin therapy

Lee JW, Kim HO, Yoon HS, Song SK, Chang BC, Kang MS

  • KMID: 1688079
  • Korean J Hematol.
  • 1991 Jun;26(1):65-71.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Congenital Hypoprothrombinemia

Lee JK, Cheon HW, Lee JH, Lee KC, Kim SK

  • KMID: 2208547
  • J Korean Pediatr Soc.
  • 1994 Mar;37(3):422-428.
Congenital hypoprothrombinemia is a rare congenital coagulation defect. The clinical signs are manifestation of generalized tendency such as; mucosal bleeding, hypermenorrhea and post tooth extraction hemorrage. It is associated with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Correlation of Prothrombin Time in Citrated Specimens and EDTA Specimens Examined by Owren Method

Ahn JJ, Park JW

  • KMID: 1889924
  • Korean J Lab Med.
  • 2002 Jun;22(3):163-168.
BACKGROUND: Sodium citrate has been used as a coagulation test because factor V and VIII are more stable in a citrated specimen. Ethylenediaminetetraacetic acid (EDTA) has been used for the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
N-acetylcysteine for Acetaminophen Poisoning Without Hepatotoxicity: the Effect on the Prothrombin Time

Lee WJ, Park KN, Choi SP, Lee MJ, Wee JH, So BH

  • KMID: 2100759
  • J Korean Soc Emerg Med.
  • 2005 Apr;16(2):281-286.
PURPOSE: In patients with acetaminophen poisoning, clinical severities are partly based on the prothrombin time. In several conditions, N-acetylcysteine (NAC) infusion has been shown to lower the prothrombin index. Thus,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Intracerebral Hemorrhage in Newborn Infants Secondary to Vitamin K Deficiency

Jung S, Kim SH, Kang SS

  • KMID: 1953098
  • J Korean Neurosurg Soc.
  • 1989 Jan;18(1):143-147.
Intracerebral hemorrhage secondary to vitamin K deficiency is presented in three newborn infants: 4 days, 28 days and 21 days of age respectively. After the administration of vitamin K(5-10 mg)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Five Cases of Hemorrhagic Disease of Infancy

Moon JS, Koh EH, Shin SM, Lee SJ

  • KMID: 1699496
  • J Korean Pediatr Soc.
  • 1982 May;25(5):518-522.
A hemorrhagic disease due to acquired prothrombin complex deficiency is presented in five infants from 3 weeks to 2 months of age. There are 2 cases of intracranial hemorrhage, 1...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Vitamin K-Deficient Hemorrhagic Disease in Infants with Acute Subdural Hematoma

Cho KY, Jung S, Oh MS

  • KMID: 1954493
  • J Korean Neurosurg Soc.
  • 1991 Nov;20(10-11):924-929.
We had experienced 2 cases of acute subdural hematoma due to vitaimin K(vit. K) deficiency. They were 44-and 42-day-old. After the adminstration of vit.K1, prolonged prothrombin time(PT) and activated partial...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Late Hemorrhagic Disease of Infancy

Kim JG, Ahn YM, Ahn HS, Choi Y, Ko KW

  • KMID: 1946126
  • J Korean Pediatr Soc.
  • 1980 Jul;23(7):572-577.
A hemorrhagic disease due to prothrombin complex deficiency os described in 4 infants from 1 to 11 months of age. This disease is different from the hemorrhagic disease of the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Performance of HemosIL ReadiPlasTin, a Liquid Reagent for Prothrombin Time Measurement

Shin S, Jung Y, Song W, Park MJ

BACKGROUND: Prothrombin time (PT) measurement is an important test for screening blood coagulation disorders and monitoring anticoagulant therapy. In this study, we evaluated the analytical performance of HemosIL ReadiPlasTin (Instrumentation...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Observations of Prothrombin Time and Activated Partial Thromboplastin Time According to Various Conditioned Specimen

Keum DG, Kim WS, Choi JW

  • KMID: 1907545
  • J Clin Pathol Qual Control.
  • 1997 Dec;19(2):297-301.
BACKGROUND: Prothrombin time (PT) and activated partial thromboplastin time (aPTT) are widely used for screening coagulation disorders in most clinical laboratories. PT and aPTT are not completely identified in significant...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Factor VII Deficiency with Normal Factor VII Antigen Level

Kwon HJ, Moon HS

  • KMID: 2038496
  • Korean J Hematol.
  • 1997 Nov;32(3):419-422.
Factor VII (FVII) deficiency is a rare hereditary disorder with a reduced FVII:C activity, which is transmitted by an autosomal recessive gene with variable expressions and a high penetrance. FVII...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Factor VLeiden and Prothrombin G20210A Gene Polymorphisms in Patients with Coronary Artery Disease

Ercan B, Tamer L, Sucu N, Pekdemir H, Camsari A, Atik U

PURPOSE: The precise molecular mechanisms culminating in coronary artery disease (CAD) are not well understood, despite a wealth of knowledge on predisposing risk factors and pathomechanisms. CAD and myocardial infarction...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Measurement of PT, aPTT, and Fibrinogen by Automatic Coagulation Analyzer, ACL9000

Kim YA, Sun YK

  • KMID: 2325360
  • J Lab Med Qual Assur.
  • 2002 Dec;24(2):201-207.
BACKGROUND: Newly developed ACL9000 automatic coagulation analyzer was evaluated in measurement of prothrombin time(PT), activated partial thromboplastin time(aPTT) and fibrinogen. METHODS: We studied precision including withtin-run and between-day precision. Normal reference...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prevalence of thromogenic gene mutations in women with recurrent miscarriage: A retrospective study of 1,507 patients

Incebiyik , Hilali NG, Camuzcuoglu A, Camuzcuoglu H, Akbas H, Kilic A, Vural M

OBJECTIVE: Thromogenic gene mutations has been thought to be associated with recurrent pregnancy loss in women in Turkey. The aim of this study was to investigate the prevalence of thromogenic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Usefulness of Plasma Abnormal Prothrombin (PIVKA-2) in Patients with Hepatocellular Carcinoma

Choi SY, Lee OJ, Kim JY, Kim YC

  • KMID: 2240660
  • Korean J Gastroenterol.
  • 1997 Sep;30(3):344-351.
BACKGROUND AND AIMS: The clinical usefulness of plasrna abnormal prothrombin (prothrombin induced by vitamin K absence or antagonist II, PIVKA-II), as a tumor marker for hepatocellular carcinoma (HCC) has been...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of the Real-Time PCR Tests for Factor V G1691A and Prothrombin G20210A with PCR-Restriction Fragment Length Polymorphism and Direct Sequencing Tests

Kim H, Lee GD, Lee SY, Jang W, Park J, Chae H, Kim M, Kim Y

BACKGROUND: Factor V (FV) G1691A and prothrombin G20210A mutations are the most common targets of genetic tests for thromboembolism. This study compared the ability of real-time PCR to detect FV...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
PIVKA-II as a Serological Marker of Hepatocellular Carcinoma

Jeong SH

  • KMID: 760665
  • Korean J Hepatol.
  • 2006 Sep;12(3):315-317.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effectiveness of Arterial Embolization in Hemodynamically Unstable Pelvic Fracture

Yoon HK, Kim MD, Han SH, Kim BK, Ahn TK

Purpose: To assess the effectiveness and appropriate time for arterial embolization with angiography in patients who sustained a hemodynamically unstable pelvic bone fracture Materials and methods: Nineteen cases with hemodynamically unstable...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Interaction of Rifampin and Warfarin

Oh YM

  • KMID: 2318258
  • Tuberc Respir Dis.
  • 1999 Dec;47(6):768-774.
BACKGROUND: It is well known that rifampin decreases the hypoprothrombinemic effect of warfarin by induction of cytochrome p-450 enzyme in healthy volunteer. However, in patients the dosage schedule o f...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Elevated Prothrombin Time-International Normalized Ratio (PT-INR) Associated with Concurrent Use of Erlotinib and Warfarin

Kim SK, Park KS, Choi SH, Byun JH, Woo IS, Han CH, Kim HL

  • KMID: 2259300
  • Korean J Med.
  • 2011 Jun;80(6):729-733.
Erlotinib, an orally active epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), is indicated for EGFR mutation-positive patients with poor performance status. Erlotinib is also used as a second-line...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr